studi
describ
syphili
seropreval
among
nearli
blood
donor
includ
syphili
seroposit
activ
infect
distribut
serolog
titr
test
process
studi
use
elisa
screen
test
use
treponema
pallidum
particl
agglutin
assay
toluidin
red
unheat
serum
test
confirm
serostatu
increas
accuraci
syphili
seropreval
lack
inform
syphili
seropreval
firsttim
donor
repeat
donor
limit
studi
object
studi
investig
associ
syphili
seropreval
age
among
blood
donor
describ
distribut
serolog
titr
among
syphilisinfect
donor
aim
confirm
syphili
epidem
characterist
promot
effect
intervent
older
adult
method
data
obtain
shenzhen
programm
syphili
prevent
control
blood
sampl
screen
use
elisa
confirm
use
treponema
pallidum
particl
agglutin
assay
tppa
toluidin
red
unheat
serum
test
trust
result
among
blood
donor
test
tppa
trust
posit
activ
infect
test
tppa
posit
histor
infect
overal
preval
syphili
seroposit
per
ci
per
preval
activ
infect
per
ci
per
peopl
age
year
display
preval
per
syphili
seroposit
per
activ
infect
time
time
higher
peopl
age
year
respect
preval
syphili
seroposit
trend
p
trend
activ
infect
trend
p
trend
increas
significantli
age
stratif
gender
year
donat
increas
trend
preval
age
remain
p
trend
except
preval
activ
infect
male
femal
donor
activ
infect
age
year
trust
titr
lower
patient
age
year
year
conclus
find
confirm
high
preval
syphili
among
older
adult
suggest
need
increas
awar
among
healthcar
provid
deliv
target
prevent
intervent
older
adult
promot
earli
test
global
popul
age
combin
result
demograph
transit
high
low
level
fertil
mortal
popul
age
increas
total
global
diseas
burden
approxim
attribut
disord
peopl
age
year
chronic
noncommunic
diseas
includ
cardiovascular
diseas
malign
neoplasm
chronic
respiratori
diseas
lead
contributor
diseas
burden
older
peopl
howev
infecti
diseas
also
consider
affect
older
peopl
increas
incid
infecti
diseas
hiv
syphili
shown
recent
surveil
data
larg
diseas
burden
among
older
peopl
call
improv
healthcar
system
invest
programm
focus
healthi
age
syphili
caus
treponema
pallidum
chronic
infect
divers
clinic
manifest
occur
distinct
stage
may
lead
blind
dementia
delirium
death
treat
immedi
adequ
syphili
also
aid
passag
hiv
invad
reduc
tcell
level
increas
viral
load
therebi
aggrav
harm
caus
hiv
even
though
syphili
effect
treat
penicillin
million
new
case
occur
annual
china
syphili
epidem
rapidli
increas
increas
per
year
first
decad
sever
acut
respiratori
syndrom
outbreak
report
incid
slightli
higher
among
femal
male
ratio
vari
significantli
age
younger
peopl
age
year
report
highest
syphili
incid
account
largest
proport
newli
report
case
howev
older
age
group
age
year
fastest
growth
incid
male
age
year
display
peak
incid
latent
syphili
last
decad
acceler
age
global
popul
increas
syphili
epidem
among
older
adult
alarm
shenzhen
special
econom
zone
locat
southern
china
popul
million
one
citi
affect
syphili
report
incid
syphili
per
last
year
much
higher
nation
incid
consist
aforement
characterist
vari
age
group
rapid
increas
syphili
incid
among
older
adult
observ
shenzhen
studi
usual
consid
blood
donor
repres
gener
popul
use
preval
data
blood
donor
realtim
surveil
identif
highrisk
group
whether
syphili
seropreval
among
blood
donor
agre
report
incid
characterist
remain
studi
shenzhen
launch
comprehens
programm
shenzhen
programm
syphili
prevent
control
spspc
novemb
enhanc
syphili
screen
among
blood
donor
five
subgroup
hiv
voluntari
counsellor
methadon
mainten
treatment
user
femal
sex
worker
men
sex
men
women
childbear
age
well
case
manag
includ
diagnosi
treatment
followup
syphilisinfect
adult
base
data
spspc
studi
aim
examin
differ
syphili
seropreval
among
blood
donor
describ
distribut
serolog
titr
among
syphilisinfect
donor
respect
age
group
confirm
syphili
epidem
characterist
southern
china
support
design
effect
intervent
older
adult
subject
blood
donat
process
blood
donor
recruit
shenzhen
blood
center
blood
mobil
shenzhen
blood
center
logo
word
nonremuner
blood
donat
dispatch
around
citi
increas
access
blood
donat
volunt
could
either
go
mobil
blood
centr
directli
donat
potenti
donor
need
sign
donat
registr
form
complet
health
histori
questionnair
undergo
rapid
test
brief
physic
examin
concis
introduct
blood
use
donat
procedur
laboratori
test
legal
regulatori
requir
shown
front
registr
form
inform
consent
obtain
donor
laboratori
test
use
blood
academ
use
data
public
report
health
histori
questionnair
contain
total
medic
condit
would
perman
temporarili
prevent
donor
donat
includ
seri
chronic
diseas
infecti
diseas
eg
hiv
syphili
transplant
highrisk
behaviour
eg
homosexu
behaviour
drug
use
surgeri
deliveri
breast
feed
predon
repaid
test
includ
blood
type
haemoglobin
hepat
b
surfac
antigen
alanin
transaminas
weight
blood
pressur
heart
rate
bodi
temperatur
measur
clinic
examin
skin
limb
conduct
peopl
conform
whole
blood
compon
donor
select
requir
gb
could
proceed
donat
blood
blood
donor
nonremuner
light
refresh
blood
donat
certif
blood
credit
allow
free
transfus
donor
direct
rel
provid
incent
donat
process
blood
manag
fulli
accord
blood
donat
law
peopl
republ
china
blood
donat
regul
shenzhen
special
econom
zone
donat
blood
sampl
transfer
shenzhen
blood
center
underw
seri
laboratori
test
elisa
two
differ
reagent
zhuhai
lizhu
bioengin
zhuhai
china
diasorin
spa
uk
branch
uk
perform
simultan
blood
sampl
syphili
screen
syphilisposit
sampl
one
screen
assay
form
list
donor
name
age
gender
transfer
shenzhen
center
chronic
diseas
control
szccc
citylevel
prevent
control
centr
sexual
transmit
diseas
std
spspc
guidelin
treponem
test
pallidum
particl
agglutin
tppa
fujirebio
tokyo
japan
nontreponem
test
toluidin
red
unheat
serum
test
trust
shanghai
rongsheng
biotech
shanghai
china
use
szccc
confirm
infect
statu
trustposit
sampl
underw
quantit
titr
test
monitor
respons
treatment
tppa
trust
result
sent
back
shenzhen
blood
center
within
day
sampl
receiv
base
serolog
test
result
syphili
seroposit
divid
histor
infect
activ
infect
consist
classif
previou
studi
histor
infect
defin
tppa
posit
trust
neg
activ
infect
tppa
trust
posit
syphili
seroposit
defin
tppa
posit
includ
trust
neg
trust
posit
moreov
hightitr
defin
quantit
titr
patient
activ
infect
purpos
studi
syphili
seroposit
repres
overal
infect
statu
among
target
popul
activ
infect
hightitr
statu
correl
diseas
activ
analys
data
donor
number
among
differ
subgroup
age
gender
year
donat
syphili
test
result
sourc
shenzhen
blood
center
szccc
respect
primari
outcom
interest
preval
syphili
seroposit
activ
infect
among
blood
donor
differ
age
group
four
age
group
year
year
fulli
consid
age
coverag
blood
donor
age
classif
previou
studi
calcul
crude
preval
ci
test
trend
use
assess
differ
preval
among
age
group
or
ci
calcul
compar
risk
syphili
seroposit
activ
infect
year
age
group
age
group
line
graph
use
describ
chang
preval
syphili
seroposit
activ
infect
among
age
group
stratif
gender
year
donat
furthermor
describ
distribut
trust
titr
among
age
group
compar
differ
use
test
trend
data
analys
use
spss
window
ibm
p
consid
statist
signific
test
patient
public
involv
develop
hypothesi
research
question
involv
develop
plan
design
implement
studi
studi
identifi
overal
preval
syphili
seroposit
among
nearli
blood
donor
per
higher
report
usa
per
brazil
per
lower
report
ethiopia
per
cameroon
per
india
per
preval
similar
mani
citi
mainland
china
xian
per
urumqi
per
kunm
per
howev
unlik
studi
use
one
method
ie
elisa
confirm
syphili
infect
statu
report
preval
studi
use
elisa
screen
test
use
tppa
trust
confirm
serostatu
screen
posit
known
elisa
method
use
worldwid
syphili
screen
sensit
specif
accord
reagent
evalu
tppa
consid
gold
standard
test
syphili
diagnosi
surprisingli
elisaposit
patient
studi
confirm
tppa
mean
posit
predict
valu
valu
associ
sensit
specif
diseas
preval
elisa
syphili
among
blood
donor
test
process
studi
greatli
reduc
number
fals
posit
increas
accuraci
syphili
seropreval
knowledg
studi
first
indepth
studi
focus
activ
infect
serolog
titr
distribut
syphili
among
blood
donor
mainland
china
activ
infect
differ
histor
infect
former
indic
transmiss
late
syphili
without
time
adequ
treatment
higher
serolog
titr
risk
transmiss
eg
mothertochild
transmiss
advers
outcom
studi
document
syphili
seroposit
donor
activ
infect
trust
titr
proport
high
titr
among
syphili
seroposit
patient
similar
report
usa
studi
found
syphili
preval
significantli
increas
age
older
adult
age
year
display
highest
preval
syphili
seroposit
activ
infect
importantli
nation
surveil
data
peopl
age
year
remark
higher
increas
report
incid
compar
age
year
hospitalis
patient
age
year
show
highest
syphili
preval
follow
patient
age
year
age
year
much
differ
hiv
infect
patient
age
year
record
highest
preval
base
result
studi
previou
studi
health
awar
syphili
prevent
focus
older
adult
need
higher
preval
among
older
adult
might
due
sever
reason
first
mani
older
peopl
sexual
activ
sexual
health
behaviour
affect
syphili
transmiss
low
selfpercept
risk
misconcept
limit
knowledg
syphili
std
frequent
report
reason
condomless
sex
among
older
adult
second
older
adult
larg
neglect
healthcar
provid
due
agerel
stigma
sexual
health
servic
hiv
std
rare
focu
older
adult
leav
group
behind
test
prevent
third
present
late
diagnosi
significantli
associ
older
age
older
peopl
like
awar
serostatu
hospit
activ
offer
test
studi
analysi
trust
result
suggest
syphilisinfect
peopl
age
year
trust
neg
low
titr
previou
infect
howev
late
present
particularli
worri
among
older
peopl
increas
risk
cardiovascular
syphili
neurosyphili
paresi
syphili
great
imit
doctor
often
ignor
syphili
infect
diagnos
elderli
lead
omiss
syphili
test
misdiagnosi
diseas
evid
suggest
signific
factor
affect
test
pattern
older
adult
activ
provis
screen
test
sinc
initi
china
nation
syphili
control
plan
syphili
screen
wide
integr
hiv
voluntari
counsel
test
vct
servic
peopl
receiv
hiv
test
servic
undergon
free
syphili
test
referr
treatment
followup
servic
would
provid
diagnos
syphili
shenzhen
half
vct
site
set
commun
health
servic
centr
separ
room
arrang
counsel
test
servic
howev
due
low
awar
selftest
older
adult
rare
posit
seek
servic
meanwhil
health
staff
unwil
provid
servic
activ
limit
experi
lack
time
discomfort
discuss
sexual
behaviour
std
older
adult
stigma
ageism
henc
enhanc
train
healthcar
provid
educ
older
adult
necessari
consist
result
previou
studi
preval
syphili
seroposit
activ
infect
higher
among
femal
male
may
stem
partli
differ
physiolog
anatomi
genit
organ
sex
lead
femal
like
contract
std
recept
vagin
sex
behaviour
studi
prove
maletofemal
transmiss
rate
higher
femaletomal
rate
certain
std
hiv
besid
proport
femal
multipl
sex
partner
lifetim
previou
studi
found
syphili
preval
among
husband
syphilisinfect
pregnant
women
premarit
extramarit
sexual
partner
may
greatli
increas
risk
syphili
infect
among
femal
addit
serolog
respons
differ
male
femal
femal
like
serofast
defin
remain
posit
nontreponem
test
keep
titr
certain
level
mostli
recommend
therapi
open
access
followup
year
accord
syphili
stage
compar
male
lead
femal
stay
state
activ
infect
exact
mechan
underli
differ
unclear
may
partli
associ
vari
immun
system
sex
furthermor
men
sex
men
consid
major
highrisk
subgroup
syphili
infect
perman
defer
blood
donat
china
studi
male
exclud
report
ever
engag
homosexu
behaviour
health
histori
questionnair
may
one
reason
low
syphili
preval
among
male
limit
studi
sever
limit
first
limit
financi
human
resourc
restrict
us
use
populationbas
design
consid
gold
standard
evalu
diseas
epidem
choic
blood
donor
popul
sampl
may
result
potenti
bia
select
bia
age
coverag
selfidentifi
health
condit
second
syphili
seropreval
among
firsttim
donor
significantli
higher
among
repeat
donor
studi
collect
inform
firsttim
donor
repeat
donor
may
lead
underestim
syphili
seropreval
third
falseneg
result
attribut
window
period
syphili
infect
may
result
underestim
syphili
seropreval
howev
residu
risk
syphili
infect
low
accord
residu
risk
analysi
conduct
shenzhen
fourth
studi
use
two
reagent
syphili
screen
sampl
one
posit
result
posit
result
would
consid
problemat
sampl
parallel
test
method
strict
suitabl
blood
donor
howev
collect
data
reagent
posit
predict
valu
calcul
respect
studi
provid
indepth
analysi
associ
syphili
seropreval
age
older
adult
show
high
preval
syphili
seroposit
activ
infect
small
proport
high
titr
point
toward
compel
need
heighten
awar
among
healthcar
provid
deliv
target
prevent
intervent
older
adult
promot
earli
test
